Featured Press Releases

Galmed releases Phase 3 Aramchol results in Hepatology.

Galmed releases Phase 3 Aramchol results in Hepatology.

Abzena Launches LabZient™, an Analytical Platform to Expedite the Path to IND for Antibodies

Abzena Launches LabZient™, an Analytical Platform to Expedite the Path to IND for Antibodies

  • 08 Feb 2024

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has...

Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time

Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time

Artax Biopharma validates AX-158, a first-in-class oral Nck modulator, in phase 2a for autoimmune disease

Artax Biopharma validates AX-158, a first-in-class oral Nck modulator, in phase 2a for autoimmune disease

Redefining Pharmaceutical Market Analytics and Insights: PharmaScroll

Redefining Pharmaceutical Market Analytics and Insights: PharmaScroll

Dupixent® outperformed Xolair® in treating CRSwNP with asthma in the first Phase 4 head-to-head trial

Dupixent® outperformed Xolair® in treating CRSwNP with asthma in the first Phase 4 head-to-head trial

  • Regeneron Pharmaceuticals, Inc.
  • 16 Jun 2025
To Target the Multi-Billion Dollar Kidney Disease Market, Mezzion Expands Its Udenafil Pipeline to ADPKD

To Target the Multi-Billion Dollar Kidney Disease Market, Mezzion Expands Its Udenafil Pipeline to ADPKD

  • Mezzion Pharmaceuticals, Inc
  • 16 Jun 2025
Ratio Therapeutics partners with Macrocyclics for exclusive production and global distribution of its Macropa™ radiopharmaceutical platform

Ratio Therapeutics partners with Macrocyclics for exclusive production and global distribution of its Macropa™ radiopharmaceutical platform

  • Ratio Therapeutics Inc.
  • 16 Jun 2025
Samsung Biologics introduces

Samsung Biologics introduces 'Samsung Organoids'—a novel drug screening service utilizing lab-grown human organ models to enhance oncology research

  • Samsung Biologics
  • 16 Jun 2025
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

  • Ibex Medical Analytics
  • 27 Aug 2024
Genmab: Epcoritamab combo shows high response in R/R DLBCL patients eligible for ASCT

Genmab: Epcoritamab combo shows high response in R/R DLBCL patients eligible for ASCT

  • Genmab
  • 13 Jun 2025
Webinar: Leverage AI for Operational Excellence and Strategic Cost Management

Most Popular
June   2025
M T W T F S S
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30            

User Area

Discover

Engage with Us

© 2024 Pharmaceutical Era — A product of HISSM. All Rights Reserved.